Pfizer shares owned by Candriam Luxembourg S.C.A.
Quarter-by-quarter ownership of Pfizer (PFE) shares owned by Candriam Luxembourg S.C.A.
from 13F filings
Historical chart of Candriam Luxembourg S.C.A. investment in Pfizer
Tip: Access up to 7 years of quarterly data
All positions including Pfizer held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Pfizer by Candriam Luxembourg S.C.A.
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $22M | 776k | 27.98 |
2024-03-31 | $36M | 1.3M | 27.75 |
2023-12-31 | $25M | 882k | 28.79 |
2023-09-30 | $23M | 702k | 33.17 |
2023-06-30 | $25M | 673k | 36.68 |
2023-03-31 | $51M | 1.4M | 37.55 |
2022-12-31 | $68M | 1.3M | 51.24 |
2022-09-30 | $63M | 1.4M | 43.76 |
2022-06-30 | $42M | 792k | 52.43 |
2022-03-31 | $21M | 409k | 51.77 |
2021-12-31 | $26M | 443k | 59.05 |
2021-09-30 | $5.8M | 134k | 43.01 |
2021-06-30 | $4.9M | 125k | 39.16 |
2021-03-31 | $5.3M | 150k | 35.31 |
2020-12-31 | $5.5M | 150k | 36.76 |
2020-09-30 | $6.5M | 178k | 36.70 |
2020-06-30 | $5.5M | 167k | 32.70 |
2020-03-31 | $20M | 509k | 38.30 |
2019-12-31 | $20k | 509k | 0.04 |
2019-09-30 | $11M | 314k | 35.93 |
2019-06-30 | $15M | 347k | 43.13 |
2019-03-31 | $17M | 399k | 42.47 |
2018-12-31 | $20M | 454k | 43.65 |
2018-09-30 | $24M | 539k | 44.07 |
2018-06-30 | $21M | 584k | 36.28 |
2018-03-31 | $28M | 789k | 35.49 |
2017-12-31 | $26M | 730k | 36.23 |
2017-09-30 | $26M | 716k | 35.70 |
2017-06-30 | $7.4M | 220k | 33.59 |
2017-03-31 | $14M | 395k | 34.21 |
2016-12-31 | $23M | 696k | 32.48 |
2016-09-30 | $34M | 1.0M | 33.87 |
2016-06-30 | $47M | 1.3M | 35.21 |
2016-03-31 | $35M | 1.2M | 29.48 |
2015-12-31 | $44M | 1.4M | 32.28 |
2015-09-30 | $45M | 1.4M | 31.41 |
2015-06-30 | $51M | 1.5M | 33.53 |
2015-03-31 | $39M | 1.1M | 34.79 |
2014-12-31 | $51M | 1.6M | 31.15 |
More positions owned by Candriam Luxembourg S.C.A.
View all positions for Candriam Luxembourg S.C.A.